GlassScriptPhysician profile
Bruce D Nicholson
NPI 1669460481
$57,527.69
in general payments reported to CMS, 2019-2025
24 companies · $1,094 in 2025
The $1,094 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $20K · 2021: $9,391 · 2022: $5,198 · 2023: $4,319 · 2024: $1,811 · 2025: $1,094.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,594 · Food and Beverage: $3,540 · Travel and Lodging: $89.73.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,593.50 |
| Food and Beverage | $3,540.43 |
| Travel and Lodging | $89.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $24,372.36 | 2019-2020 | |
| Medtronic, INC. | $16,454.03 | 2021-2025 | Intellis Adaptivestim, Synchromedii, Inceptiv |
| Collegium Pharmaceutical, INC. | $7,971.42 | 2019-2021 | |
| Lilly USA, LLC | $3,325.00 | 2020 | |
| Myovant Sciences INC. | $2,050.00 | 2021 | |
| Grt US Holding, INC. | $1,348.86 | 2020-2022 | |
| Abbott Laboratories | $435.77 | 2019-2025 | Proclaim, Eterna |
| Vertos Medical, INC. | $377.68 | 2022-2024 | Mild Device Kit |
| Stryker Corporation | $322.77 | 2022-2025 | Mild Device Kit, Optablate |
| Boston Scientific Corporation | $232.23 | 2021-2023 | Infinion 16 |
| Painteq LLC | $158.12 | 2022 | |
| Averitas Pharma INC. | $94.62 | 2023 | Qutenza |
| Spinal Simplicity, LLC | $87.59 | 2022 | |
| Johnson & Johnson Health Care Systems INC. | $50.88 | 2021 | |
| Tersera Therapeutics LLC | $44.67 | 2020-2025 | Prialt |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scilex Pharmaceuticals INC. | $31.98 | 2019 | |
| Merz North America, INC. | $28.60 | 2022 | |
| Amgen INC. | $25.25 | 2023 | Tavneos, Enbrel |
| Vertiflex, INC. | $24.90 | 2019 | |
| Pfizer INC. | $22.42 | 2019 | |
| Ucb, INC. | $19.54 | 2023 | Cimzia |
| Almatica Pharma LLC | $18.77 | 2021 | |
| Abbvie INC. | $16.74 | 2023 | |
| Biodelivery Sciences International, INC. | $13.49 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Nicholson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.